CEBPD as a Regulator of Brain Disease in Mice Lacking Prosaposin
Author Information
Author(s): Sun Ying, Jia Li, Williams Michael T, Zamzow Matt, Ran Huimin, Quinn Brian, Aronow Bruce J, Vorhees Charles V, Witte David P, Grabowski Gregory A
Primary Institution: Cincinnati Children's Hospital Medical Center
Hypothesis
CEBPD may play a role in the progression of brain disease in prosaposin deficient mice.
Conclusion
The study found that specific gene expression changes occur before observable neurological deficits in prosaposin deficient mice, with CEBPD identified as a key regulator.
Supporting Evidence
- CEBPD was the only up-regulated transcription factor in all three mouse models studied.
- Gene expression changes were detected at birth, prior to any neurological deficits.
- Proinflammatory gene expression increased with age in all models.
Takeaway
Mice that lack a protein called prosaposin show brain problems, and scientists found that a gene called CEBPD might help explain why these problems happen.
Methodology
The study used microarray analyses to examine gene expression in three different mouse models of prosaposin deficiency.
Potential Biases
Potential bias in gene expression analysis due to the use of pooled RNA samples.
Limitations
The study primarily focused on mouse models, which may not fully replicate human conditions.
Participant Demographics
Mice were of various strains including FVB and mixed strains.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website